2013
DOI: 10.1016/j.rec.2012.11.013
|View full text |Cite
|
Sign up to set email alerts
|

Functional Improvement in Patients With Dilated Cardiomyopathy After the Intracoronary Infusion of Autologous Bone Marrow Mononuclear Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2013
2013
2019
2019

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 35 publications
0
1
0
1
Order By: Relevance
“…Various clinical outcomes have shown the regenerative capability of BMMNCs in subspecialties of medical fields such as plastic surgery, orthopedic surgery, oral and maxillofacial surgery, and cardiac surgery [35, 39, 40, 45]. These preliminary results suggest that BMMNCs-assisted lipotransfer could be effective and safe for soft tissue augmentation and superior to conventional lipoinjection.…”
Section: Discussionmentioning
confidence: 95%
“…Various clinical outcomes have shown the regenerative capability of BMMNCs in subspecialties of medical fields such as plastic surgery, orthopedic surgery, oral and maxillofacial surgery, and cardiac surgery [35, 39, 40, 45]. These preliminary results suggest that BMMNCs-assisted lipotransfer could be effective and safe for soft tissue augmentation and superior to conventional lipoinjection.…”
Section: Discussionmentioning
confidence: 95%
“…Los ensayos clínicos en fase I y II concuerdan en señalar que la administración intracoronaria o intramiocárdica de células madre de diversos orígenes, en pacientes con insuficiencia cardiaca es segura [1][2][3][4][5][6][7] . Respecto a la eficacia de esta terapia, se han descrito beneficios significativos sobre la capacidad funcional, la calidad de vida y un aumento de la fracción de eyección del ventrículo izquierdo (FEVI) [1][2][3][4][5][6][7] . Pese a sugerir un beneficio importante dentro del primer año, es limitado el número de ensayos con seguimiento prolongado, en pacientes sometidos a terapia celular [4][5][6] .…”
unclassified